Recourse Biologics is committed to advancing new and improved therapies for oncology.

Our lead molecule is RB101. RB101 is a first-in-class immunotherapeutic that increases professional killer cell persistence, memory formation, and cytotoxicity without systemic toxicity or exhaustion. RB101 is 12 months from IND.

In addition to RB101, Recourse Biologics has created an improved method of targeting and redirecting cytotoxic lymphocytes within the tumor microenvironment using our bispecific antibody platform.

Recourse Biologics

Org chart

Teams

Offices

Recourse Biologics

Org chart

Teams

Offices

Related companies